Plexus Corp (PLXS) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Plexus Corp stock $157, price $192, that is 18.1% below the price, quality 62 out of 100. Rating: overvalued. Calculated from audited financials with 23 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.
How to read this chart
60‑month range $74.57 – $303.82 · fair‑value band $88.65 – $204.70 · the $192.17 price screens above the $157.46 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 3, 2026.
Follow Plexus in your weekly email
Every Wednesday you see whether Plexus is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Plexus Corp. provides electronic manufacturing services in the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services.
Show moreShow less
It serves the aerospace/defense, healthcare/life sciences, and industrial/commercial sectors. Plexus Corp. was founded in 1979 and is headquartered in Neenah, Wisconsin.
Stock analysis
Plexus Corp (PLXS) currently trades at $192.17, while our model-based Fair Value estimate is $157.46, 18% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of $173.01 per share, and 6 of the 23 models we run sit above the $192.17 price.
Bear case: the Asset-Based group reads lowest at $30.08, and 17 of the 23 models stay below the price. Data coverage for this calculation is medium.
Scenario range: $88.65 (bear) to $204.70 (bull), the price of $192.17 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 62/100 (solid quality), in the Technology sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Plexus Corp reported revenue of $5.0B in FY2026 versus $3.8B in FY2022, a compound +6.8%/yr. Reported net income was $202M in FY2026, compounding +10.0%/yr from FY2022.
Key figures
Market cap $6.4B Mid · P/E ratio 28.4 · P/S ratio 1.39 · EPS (TTM) $6.77 · Net margin 4.0% · Return on equity 12.6% · Return on assets (EBIT) 5.9% (5-year average) · Operating margin 4.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 37% below its 52-week high and 45% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −7% fair-value upside, at −18%, PLXS screens richer than that median.
Fair Value models
Bear$88.65Fair Value $157.46Bull$204.70
Price $192.17 · Downside -18.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 1 months old). Earnings retained since then ($0.7234 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
In the last 6 months, 5 officers or directors sold shares worth $5.2M and none bought.
SaleTodd P. KelseyPresident & CEO, Director13× since Feb 3, 2026: 33,754 shares, avg. $234.29$7.9MOct 21, 2026
SaleKaren Marie RappDirector4× since Nov 28, 2025: 2,000 shares, avg. $212.48$424,965Aug 31, 202610b5-1 plan
SaleMichael Schrock VDirector4,000 shares at $275.00$1.1MAug 11, 202610b5-1 plan
SaleMichael J. RunningRegional President - AMER3× since Feb 2, 2026: 2,136 shares, avg. $221.16$472,392Jun 5, 2026
SaleVictor (Pang Hau) TanRegional President - APAC2× since Feb 6, 2026: 6,000 shares, avg. $238.37$1.4MMay 11, 2026
SaleAngelo Michael Ninivaggi JrEVP, Chief Legal & PAO & Secy4× since Nov 10, 2025: 13,718 shares, avg. $211.57$2.9MMay 8, 2026
SaleRandy J MartinezDirector1,000 shares at $203.14$203,140Feb 25, 2026
SaleOliver K. MihmExec VP & COO3× since Nov 10, 2025: 15,842 shares, avg. $186.38$3.0MFeb 18, 2026
SalePatrick John JermainExec. VP & CFO4× since Nov 11, 2025: 12,749 shares, avg. $194.02$2.5MFeb 12, 2026
SaleFrank ZycinskiRegional President - EMEA1,399 shares at $205.99$288,180Feb 12, 2026
Plus 1 more entries from the last 12 months.
Plus one other filing such as a grant, option exercise or tax withholding. It is not a market purchase or sale.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.67/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+23.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.1%
Start year 2021 (pandemic). Over 10 years: +6.9% a year
Revenue growth 41 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.5%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+9.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+9.2%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.9.2% vs 10.4%, steady
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 5%
Pace: the 5-year rate starts in 2021 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+34.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+10.8%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +31.1% a year for the price and +8.3% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (97 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
AI conclusion: Plexus shows moderate business quality with an expanded manufacturing opportunity funnel in aerospace, defense and healthcare as its main strength, yet faces challenges converting that pipeline into steady cash flows and margins amid capital demands.
Main risk: Ramp delays in scaling new contract manufacturing programs could prevent conversion of the pipeline into steady cash flows and margins under the sector's capital demands.
Plexus has expanded its qualified manufacturing opportunity funnel to a record 4.5 billion dollars, driven by new programs in aerospace, defense and healthcare. The real test lies in converting that pipeline into steady cash flows and margins amid the capital demands of contract manufacturing. Our models currently see the stock as overvalued. Will execution keep pace with the funnel or will ramp delays erode the returns?
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electronic Components · 651 stocks
Beats the industry median on 7/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score62 · Above median
Fair Value upside−18.1% · Above median
Profitability
Return on equity (12 months)12.6% · Above median
Return on assets5.2% · Above median
Net margin (12 months)4.0% · Below median
Operating margin (12 months)4.7% · Below median
Growth and dividend
Revenue growth (quarter YoY)28.1% · Above median
Balance sheet
Debt / equity0.06× · Below median
Valuation Multiplesvs Electronic Components median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Plexus Corp Fair Value". https://www.fairvalue-calculator.com/stock/PLXS
Frequently asked questions
Is Plexus Corp (PLXS) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of $157.46 versus a price of $192.17, about 18% lower (overvalued).
What is the fair value of PLXS?
Our model-based fair value for Plexus Corp is $157.46 (as of Nov 3, 2026), built from audited fundamentals. The current price: $192.17.
What is the quality score of PLXS?
Plexus Corp has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Plexus Corp (PLXS)?
Our model-based price target is the fair value of $157.46 (as of Nov 3, 2026) from 23 valuation models. Cautious scenario $88.65, optimistic scenario $204.70. It is a calculation from audited fundamentals, not an analyst target.
What is the Plexus Corp stock forecast for 2026?
Our models put fair value at $157.46, about 18% lower versus a price of $192.17 (overvalued). Cautious scenario $88.65, optimistic scenario $204.70. The calculation is refreshed regularly with new filings.
What is the revenue of Plexus Corp (PLXS)?
Plexus Corp reported trailing-twelve-month revenue of about $4.6B (latest available figure, as of Nov 3, 2026).
What growth is priced into Plexus Corp (PLXS)?
For today's price to be fair in a discounted-cash-flow model, Plexus Corp would have to grow free cash flow by +34.2 % per year for five years (discount rate 9.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +8.1 % per year. As of Nov 3, 2026.
What discount rate (WACC) does the fair value of PLXS use?
Our models discount Plexus Corp at 9.5 %: a base by market capitalisation (mid), damped by beta 0.89, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Plexus Corp that is +34.2 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.5 %) and the same formula as our fair value.
How much growth has Plexus Corp (PLXS) delivered so far?
Over the past 5 years revenue at Plexus Corp grew +8.1 % a year. The price currently implies free-cash-flow growth of +34.2 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Plexus Corp (PLXS) growing?
The median revenue growth in the sector is +11.5 % a year. That is the yardstick for the growth priced into Plexus Corp (+34.2 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Plexus Corp (PLXS)?
The free-cash-flow yield on the price is 1.30 %: that much free cash flow Plexus Corp produces per unit of market value. When it exceeds the discount rate of our models (9.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Plexus Corp (PLXS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Plexus Corp it is $157.46 per share (as of Nov 3, 2026), against a price of $192.17. It is the blended result of 23 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Plexus Corp stock overvalued or undervalued in 2026?
As of Nov 3, 2026, PLXS trades above its calculated fair value: price $192.17, fair value $157.46, a gap of about −18% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PLXS?
No. The price is what the market pays today ($192.17); the fair value is what the company's own numbers justify ($157.46). For Plexus Corp the two are $34.71 per share apart. That gap is exactly why we show both numbers side by side.
How much is Plexus Corp worth?
The market values Plexus Corp at about $6.4B (market capitalisation, as of Nov 3, 2026). Per share that is $192.17; our models calculate a fair value of $157.46 per share.
What do the bullish and bearish scenarios say about PLXS?
Our models span a range for Plexus Corp: cautious scenario $88.65, base $157.46, optimistic $204.70 per share (as of Nov 3, 2026, price $192.17). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of PLXS?
Plexus Corp trades at a price-to-earnings ratio of 28.4 (as of Nov 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $157.46 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2017 to 2026), reported earnings, FY2020, FY2023, FY2024 ex one-offs: 18.4. Other multiples: PEG 2.1, P/B 4.1, P/S 1.4, EV/EBITDA 20.2.
What is the PEG ratio of PLXS?
The PEG ratio of Plexus Corp is 2.09 (P/E divided by earnings growth, as of Nov 3, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Plexus Corp (PLXS)?
Balance-sheet figures for Plexus Corp (as of Nov 3, 2026): return on equity 12.6%, debt of 0.06 per unit of equity. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
How far is PLXS from its 52-week high?
Plexus Corp trades at $192.17, about 37% below its 52-week high of $303.82 and 45% above the low of $132.74 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $157.46 is for.
Which stocks are comparable to Plexus Corp?
From the same area (Technology) we also value Amphenol Corporation, Hon Hai Precision Industry Co, Corning Incorporated, Delta Electronics, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Plexus Corp stock attractive at the current price?
The data as of Nov 3, 2026: price $192.17, calculated fair value $157.46 (−18%), Quality Score 62/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PLXS calculated?
We run Plexus Corp through 23 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $157.46 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Plexus Corp itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Plexus Corp (PLXS)?
The closing price on Nov 6, 2026 was $192.17. Our model-based fair value is $157.46, about 18% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Plexus Corp right now?
Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($88.65 to $204.70) leaves room in how you read the outcome.
Where does the earnings growth of Plexus Corp (PLXS) come from?
Earnings per share at Plexus Corp grew +8.8 % a year from 2015 to 2026. Broken into its drivers: revenue per share +8.5 %, EBIT margin +1.0 %, tax rate −0.4 %, residual (interest, one-offs) −0.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Plexus Corp
How large is the market capitalisation of Plexus Corp (PLXS)?
The market capitalisation of Plexus Corp is $6.4B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Plexus Corp (PLXS)?
The price-to-sales ratio of Plexus Corp is 1.39 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Plexus Corp (PLXS)?
Earnings per share at Plexus Corp are $6.77 (price ÷ EPS = P/E 28.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Plexus Corp (PLXS)?
The net margin of Plexus Corp is 4.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Plexus Corp (PLXS)?
The return on equity (ROE) of Plexus Corp is 12.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Plexus Corp (PLXS)?
On an EBIT basis the return on assets of Plexus Corp is 5.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Plexus Corp (PLXS)?
The operating margin of Plexus Corp is 4.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Plexus Corp (PLXS)?
Revenue at Plexus Corp is growing +28.1% versus a year earlier (3y avg +5.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Plexus Corp (PLXS)?
Earnings per share at Plexus Corp are growing −3.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Plexus Corp (PLXS) carry?
The net debt of Plexus Corp is $2.6M (fiscal year 2026, ≈ 0.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Plexus Corp in the live analysis
One click puts Plexus Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 3, 2026